Clinical trials
Acute Kidney Injury trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 5 |
| Recruiting | 3 |
| Withdrawn | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 5 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Onze Lieve Vrouwe Gasthuis | 2 |
| Radboud University Medical Center | 2 |
| University Medical Center Groningen | 2 |
| AM-Pharma | 1 |
| Alere San Diego | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Amsterdam UMC | 1 |
| Amsterdam UMC, location VUmc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Kidney Injury | 31 |
| Renal Insufficiency | 4 |
| Shock | 3 |
| Acute Disease | 2 |
| Hemorrhage | 2 |
| Renal Insufficiency, Chronic | 2 |
| Sepsis | 2 |
| Shock, Septic | 2 |
| Anaphylaxis | 1 |
| Aortic Valve Disease | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.